FOSAPREPITANT-AFT fosaprepitant (as dimeglumine) 150 mg powder for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

fosaprepitant-aft fosaprepitant (as dimeglumine) 150 mg powder for injection vial

aft pharmaceuticals pty ltd - fosaprepitant dimeglumine, quantity: 245.3 mg (equivalent: fosaprepitant, qty 150 mg) - injection, powder for - excipient ingredients: dilute hydrochloric acid; polysorbate 80; lactose; disodium edetate; sodium hydroxide - fosaprepitant-aft, in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of:,? highly emetogenic cancer chemotherapy (see section 4.2 dose and method of administration),? moderately emetogenic cancer chemotherapy (see section 4.2 dose and method of administration).

Aprepitant Rontis Capsules Hard 80mg Malta - English - Medicines Authority

aprepitant rontis capsules hard 80mg

rontis hellas medical and pharmaceutical products s.a. 38, sorou str., athens, maroussi, 15125, greece - aprepitant - hard capsule - aprepitant 80 mg - antiemetics and antinauseants

Aprepitant Rontis Capsules Hard 125mg Malta - English - Medicines Authority

aprepitant rontis capsules hard 125mg

rontis hellas medical and pharmaceutical products s.a. 38, sorou str., athens, maroussi, 15125, greece - aprepitant - hard capsule - aprepitant 125 mg - antiemetics and antinauseants

Aprepitant Rontis Capsules Hard 80mg & 125mg Malta - English - Medicines Authority

aprepitant rontis capsules hard 80mg & 125mg

rontis hellas medical and pharmaceutical products s.a. 38, sorou str., athens, maroussi, 15125, greece - aprepitant - hard capsule - aprepitant 80 mg aprepitant 125 mg - antiemetics and antinauseants

Aprepitant Accord 125 mg hard capsules Ireland - English - HPRA (Health Products Regulatory Authority)

aprepitant accord 125 mg hard capsules

accord healthcare ireland ltd. - aprepitant - capsule, hard - 125 milligram(s) - aprepitant

Aprepitant Accord 125 mg/80 mg hard capsules Ireland - English - HPRA (Health Products Regulatory Authority)

aprepitant accord 125 mg/80 mg hard capsules

accord healthcare ireland ltd. - aprepitant; aprepitant - capsule, hard - 80/125 milligram(s) - aprepitant

Aprepitant Accord 80 mg hard capsules Ireland - English - HPRA (Health Products Regulatory Authority)

aprepitant accord 80 mg hard capsules

accord healthcare ireland ltd. - aprepitant - capsule, hard - 80 milligram(s) - aprepitant

APREPITANT ARX aprepitant 80 mg & 125 mg tri-pack capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

aprepitant arx aprepitant 80 mg & 125 mg tri-pack capsule blister pack

arrotex pharmaceuticals pty ltd - aprepitant, quantity: 80 mg - capsule - excipient ingredients: hypromellose; poloxamer; sucrose; microcrystalline cellulose; gelatin; titanium dioxide; sodium lauryl sulfate; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - aprepitant, in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of: - highly emetogenic cancer chemotherapy. - moderately emetogenic cancer chemotherapy. aprepitant is indicated for the prevention of postoperative nausea and vomiting.

APREPITANT ARX aprepitant 80 mg capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

aprepitant arx aprepitant 80 mg capsule blister pack

arrotex pharmaceuticals pty ltd - aprepitant, quantity: 80 mg - capsule - excipient ingredients: hypromellose; poloxamer; sucrose; microcrystalline cellulose; gelatin; sodium lauryl sulfate; titanium dioxide; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - aprepitant, in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of: - highly emetogenic cancer chemotherapy. - moderately emetogenic cancer chemotherapy. aprepitant is indicated for the prevention of postoperative nausea and vomiting.

APREPITANT ARX aprepitant 40 mg capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

aprepitant arx aprepitant 40 mg capsule blister pack

arrotex pharmaceuticals pty ltd - aprepitant, quantity: 40 mg - capsule - excipient ingredients: hypromellose; poloxamer; sucrose; microcrystalline cellulose; gelatin; sodium lauryl sulfate; titanium dioxide; iron oxide yellow; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - aprepitant, in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of: - highly emetogenic cancer chemotherapy. - moderately emetogenic cancer chemotherapy. aprepitant is indicated for the prevention of postoperative nausea and vomiting.